000			03449nam a2200433 i 4500
999			_c362845 _d362845 _x1
001			362845
003			ES-MaUEC
005			20230102121623.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			210524s2021 sz | o |||| 0|eng d
020			_a9783030669737
024	7		_a10.1007/978-3-030-66973-7 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM302.5 _b2021 EB
245	0	0	_aDrug-Induced Oral Complications _cedited by Sarah Cousty, Sara Laurencin-Dalicieux
250			_aFirst edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
300			_a1 recurso en línea (VII, 125 páginas) _b73 ilustraciones, 71 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
505	0		_aAdverse Drug Reactions in the Orofacial Region: How Does it Work? -- Drug-Induced Gingival Overgrowth -- Drug-Induced Oral Mucosa Pigmentation -- Oral Manifestations of Drug Allergy -- Drug-Induced Oral Ulcerations -- Drug-Induced Oral Lichenoid Reactions / White Lesions -- Drug-Induced Osseous Complications -- Drug-Induced Oral Bleeding -- Drug-Induced Taste Disturbances -- Drug-Induced Salivary Gland Disturbances : Xerostomia, Pain, Swelling, Hypersalivation, Discoloration of Saliva -- Drug-Induced Oral Infections -- Drug-Induced Peri-Oral and Facial Complications.
520			_aThis book provides detailed information on the prevalence and manifestations of the most important oral complications associated with different drug treatments, focusing especially on recently developed therapies. Among the diverse adverse drug reactions covered are gingival overgrowth, ulcerations, lichenoid reactions, pigmentation, and bullous reactions. The potential direct toxic effects on bone of drugs that prevent bone mass loss, such as bisphosphonates and denosumab, are fully examined, as is the occurrence of spontaneous oral bleeding in patients receiving antithrombotic therapies. Further chapters focus on drug-induced taste disorders and salivary gland disturbances, including xerostomia, swelling, and hypersalivation. The enhanced risk of oral infections when using chemotherapy and biotherapy is addressed, and the closing chapter examines drug-related perioral and facial complications. This book is a collaborative work that brings together clinicians, surgeons, and specialists in drug safety surveillance. It will be of value for all dental and medical practitioners who encounter these complications in their clinical practice.
988			_aSpringer_Medicine_2021
650		7	_2embne _9169576 _aMedicamentos _xInteracción
700	1		_aCousty, Sarah _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aLaurencin-Dalicieux, Sara _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783030669720
776	0	8	_iPrinted edition: _z9783030669744
776	0	8	_iPrinted edition: _z9783030669751
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-66973-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2022 _dz _eb _zSI